Skip to main content
Journal cover image

Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma.

Publication ,  Journal Article
Mummy, DG; Kruger, SJ; Zha, W; Sorkness, RL; Jarjour, NN; Schiebler, ML; Denlinger, LC; Evans, MD; Fain, SB
Published in: J Allergy Clin Immunol
March 2018

Ventilation defect percent (VDP) measured in asthmatics with hyperpolarized helium-3 MRI was more strongly associated with ED visits and hospitalizations due to asthma exacerbation than were conventional biomarkers of lung function and inflammation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Allergy Clin Immunol

DOI

EISSN

1097-6825

Publication Date

March 2018

Volume

141

Issue

3

Start / End Page

1140 / 1141.e4

Location

United States

Related Subject Headings

  • Pulmonary Ventilation
  • Male
  • Magnetic Resonance Imaging
  • Lung
  • Isotopes
  • Humans
  • Helium
  • Female
  • Asthma
  • Allergy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mummy, D. G., Kruger, S. J., Zha, W., Sorkness, R. L., Jarjour, N. N., Schiebler, M. L., … Fain, S. B. (2018). Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma. J Allergy Clin Immunol, 141(3), 1140-1141.e4. https://doi.org/10.1016/j.jaci.2017.10.016
Mummy, David G., Stanley J. Kruger, Wei Zha, Ronald L. Sorkness, Nizar N. Jarjour, Mark L. Schiebler, Loren C. Denlinger, Michael D. Evans, and Sean B. Fain. “Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma.J Allergy Clin Immunol 141, no. 3 (March 2018): 1140-1141.e4. https://doi.org/10.1016/j.jaci.2017.10.016.
Mummy DG, Kruger SJ, Zha W, Sorkness RL, Jarjour NN, Schiebler ML, et al. Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma. J Allergy Clin Immunol. 2018 Mar;141(3):1140-1141.e4.
Mummy, David G., et al. “Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma.J Allergy Clin Immunol, vol. 141, no. 3, Mar. 2018, pp. 1140-1141.e4. Pubmed, doi:10.1016/j.jaci.2017.10.016.
Mummy DG, Kruger SJ, Zha W, Sorkness RL, Jarjour NN, Schiebler ML, Denlinger LC, Evans MD, Fain SB. Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma. J Allergy Clin Immunol. 2018 Mar;141(3):1140-1141.e4.
Journal cover image

Published In

J Allergy Clin Immunol

DOI

EISSN

1097-6825

Publication Date

March 2018

Volume

141

Issue

3

Start / End Page

1140 / 1141.e4

Location

United States

Related Subject Headings

  • Pulmonary Ventilation
  • Male
  • Magnetic Resonance Imaging
  • Lung
  • Isotopes
  • Humans
  • Helium
  • Female
  • Asthma
  • Allergy